CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor.
McLean
S
S
Department of Neuroscience, Pfizer, Inc., Groton, CT 06340.
Snider
R M
RM
Desai
M C
MC
Rosen
T
T
Bryce
D K
DK
Longo
K P
KP
Schmidt
A W
AW
Heym
J
J
D000420:Albuterol / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism; D002211:Capsaicin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D007700:Kinetics; D008168:Lung / Q000187:drug effects / Q000502:physiology; D015288:Neurokinin A / Q000037:antagonists & inhibitors*; D064729:Neurokinin-1 Receptor Antagonists; D010880:Piperidines / Q000378:metabolism / Q000494:pharmacology*; D018040:Receptors, Neurokinin-1 / Q000378:metabolism / Q000502:physiology; D015244:Thiorphan / Q000494:pharmacology; D014700:Verapamil / Q000031:analogs & derivatives / Q000378:metabolism
D015220:Calcium Channels; D064729:Neurokinin-1 Receptor Antagonists; D010880:Piperidines; D018040:Receptors, Neurokinin-1; C080755:3-(2-methoxybenzylamino)-2-phenylpiperidine; D015288:Neurokinin A; C043184:4-desmethoxyverapamil; D015244:Thiorphan; D014700:Verapamil; D000420:Albuterol; D002211:Capsaicin